Clinical trial
A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder (DSWPD)
NCT04652882 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder (DSWPD)
- Lead sponsor
- Vanda Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 9, 2020
- Completion date
- September 4, 2026
- Enrollment
- 43 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.